5/27/20 16:11 | 5/26/20 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 100 | 9.75 | 0 | 10 | 1 | 825 | I | | | | | | | | | | | | | | |
10/8/19 16:25 | 10/6/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 2 | 816 | D | | | | | | | | | | | | | | |
8/8/19 16:38 | 8/8/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 25 | 10.85 | 0 | 2 | 0 | 806 | D | | | | | | | | | | | | | | |
5/13/19 09:15 | 5/10/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 50 | 12.48 | 0 | 4 | 1 | 802 | D | | | | | | | | | | | | | | |
3/13/19 16:11 | 3/12/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 50 | 12.36 | 0 | 4 | 1 | 798 | D | | | | | | | | | | | | | | |
1/4/19 17:03 | 1/3/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | S | -41 | 12.36 | 0 | -3 | 0 | 794 | D | | | | | | | | | | | | | | |
11/13/18 09:17 | 11/9/18 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 85 | 17.10 | 0 | 5 | 1 | 797 | M | | | | | | | | | | | | | | |
10/9/18 16:31 | 10/8/18 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 2 | 792 | D | | | | | | | | | | | | | | |
8/10/18 09:13 | 8/9/18 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 223 | 22.33 | 0 | 10 | 1 | 783 | D | | | | | | | | | | | | | | |
11/9/17 09:13 | 11/8/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 118 | 23.60 | 0 | 5 | 1 | 743 | D | | | | | | | | | | | | | | |
10/10/17 16:39 | 10/6/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 2 | 738 | D | | | | | | | | | | | | | | |
6/6/17 18:47 | 6/5/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 86 | 17.23 | 0 | 5 | 1 | 728 | D | | | | | | | | | | | | | | |
11/23/16 20:17 | 11/23/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 31 | 18.41 | 9 | 2 | 0 | 723 | D | 8 | 4 | 57 | 8 | -5 | -3 | -17 | 0 | -1 | -11 | 0 | 4 | | |
11/23/16 08:35 | 11/22/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 30 | 17.95 | 9 | 2 | 0 | 721 | D | 8 | 4 | 57 | 8 | -5 | -3 | -17 | 0 | 3 | -8 | 3 | 7 | | |
11/22/16 14:28 | 11/21/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 30 | 17.90 | 9 | 2 | 0 | 719 | D | 4 | 6 | 55 | 0 | -5 | -8 | -17 | -1 | 1 | -3 | 1 | 6 | | |
5/24/16 17:26 | 5/23/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | M.d | 2 | 0.1626 | 2 | 10 | 1 | 718 | D | -15 | -45 | -37 | 2 | -11 | -6 | 23 | 4 | -1 | 56 | 22 | 61 | 63 | |
5/23/16 16:04 | 5/20/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 21 | 10.41 | 2 | 2 | 0 | 706 | D | -16 | -45 | -41 | -4 | -11 | -1 | 11 | 9 | 9 | 47 | 30 | 69 | 71 | |
5/20/16 17:52 | 5/19/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.65 | 2 | 2 | 0 | 704 | D | -23 | -51 | -43 | -11 | -18 | -7 | -4 | 0 | 1 | 70 | 37 | 75 | 79 | |
5/19/16 17:30 | 5/18/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 20 | 10.23 | 2 | 2 | 0 | 702 | D | -19 | -46 | -38 | -14 | -16 | -5 | 1 | 17 | 8 | 17 | 35 | 79 | 104 | |
5/18/16 17:22 | 5/17/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.73 | 2 | 2 | 0 | 700 | D | -24 | -50 | -44 | -26 | -22 | -10 | -2 | 12 | -5 | 14 | 38 | 78 | 112 | |
5/17/16 18:10 | 5/16/16 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | P | 19 | 9.51 | 2 | 2 | 0 | 698 | D | -25 | -48 | -43 | -11 | -12 | -20 | -4 | 3 | 7 | 10 | 43 | 85 | 124 | |
3/25/15 16:01 | 3/24/15 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Clayman Michael D. | MA | DO | P,CEO | M.d | 1 | 0.1626 | 2 | 5 | 1 | 694 | D | | 38 | 43 | 16 | 20 | -2 | -4 | -15 | 0 | -1 | -17 | -3 | 9 | -57 |